Hi, I'm Matt Turner, the editor in chief of business at Insider. Welcome back to Insider Today's Sunday edition, a roundup of some of our top stories. On the agenda today: |
|
|
DISPATCH The big RTO battle |
|
|
THIS WEEK'S STORIES A 'Willy Wonka fun house' gone wrong |
| | Killing off projects had become something of a tradition at Kittyhawk, the secretive flying-car startup launched by Larry Page. But when the Google cofounder decided to get more hands-on, what followed was a series of bizarre experiments, ostensibly intended to save the company. A dozen former Kittyhawk employees told Insider that Kittyhawk found itself torn between the conflicting visions and shifting priorities of its billionaire founder and his handpicked CEO. In the end, the internal chaos proved unsustainable. The spectacular rise and fall of Kittyhawk. |
|
|
Getty Images; Alyssa Powell/Insider |
For millions of Americans, the past few years have redefined their relationship to money. Gen Z and millennials, in particular, have seen the critical years of their financial lives defined by the shifting sands of the pandemic economy. Experts say the financial scars of the pandemic era run deep. And as overlapping crises only intensify in the next few decades, the behaviors young people develop around money will stick around. How the cycle of scarcity and splurging will reshape the economy. | |
|
Each decade brings some turning point in technology that lures college students to a new field — and right now, artificial intelligence is all the rage. Students and recent grads are embracing AI, with many hoping to be an early employee at the next big tech giant. We spoke with a dozen professors, students, and industry professionals about how companies are raiding college campuses to mine for talent, offering six-figure salaries and unimaginable resources. "The student population is getting cleaned out," one dean from Cornell said. Inside the AI talent wars. |
|
|
A wave of revolutionary weight-loss drugs, which includes the buzzy Ozempic, represents a watershed moment for obesity treatment. But high costs, insurance hurdles, and a surge in demand are keeping the drugs from getting to many of the people who need them. Doctor offices are overwhelmed by patients asking for the drugs for cosmetic reasons. Celebrities and influencers are raising the drugs' profile even further. But people who need the treatment the most are stuck in the middle. More on the $100 billion tug-of-war. | |
|
"You just go online, make up a fake name, and that's it — you're up and running. No one's regulating." |
|
|
MORE TOP READS Solving traffic, a landlord reckoning, & more | |
|
CAN'T GET ENOUGH? Keep up with Insider | - Get Insider's app and notifications to be the first to find out about the stories you want to know — from tech to business. Download it here.
- Become an Insider subscriber to get actionable, high-value news and insights to improve your career, company, and community. Subscribe here.
- Want more of Insider in your inbox? Sign up for our newsletters here.
|
This edition was curated by Matt Turner, and edited by Dave Smith and Lisa Ryan. Get in touch: insidertoday@insider.com. |
|
|
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.